Reproducibility of PET studies with L-[β-11C]DOPA and [18F]FE-PE2I in healthy humans

被引：0
|
作者：
Suzuki, Masayuki [1 ]
Ito, Hiroshi [1 ]
Takano, Harumasa [1 ]
Fujiwara, Hironobu [1 ]
Kimura, Yasuyuki [1 ]
Kodaka, Fumitoshi [1 ]
Varrene, Andrea [2 ]
Okubo, Yoshiro [3 ]
Suhara, Tetsuya [1 ]
机构：
[1] Natl Inst Radiol Sci, Mol Neuroimaging Program, Mol Imaging Ctr, Chiba 260, Japan
[2] Karolinska Inst, Karolinska Hosp, Dept Clin Neurosci, Ctr Psychiat Res, S-10401 Stockholm, Sweden
[3] Nippon Med Sch, Dept Neuropsychiat, Tokyo 113, Japan
来源：
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM | 2012年 / 32卷
关键词：
BRAIN;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S131 / S131
页数：1
相关论文
共 50 条
  • [21] PET imaging of dopamine transporters with [18F]FE-PE2I: Effects of anti-Parkinsonian drugs
    Bang, Ji-In
    Jung, In Soon
    Song, Yoo Sung
    Park, Hyun Soo
    Moon, Byung Seok
    Lee, Byung Chul
    Kim, Sang Eun
    NUCLEAR MEDICINE AND BIOLOGY, 2016, 43 (02) : 158 - 164
  • [22] Fully Automated GMP-Compliant Synthesis of [18F]FE-PE2I
    Bratteby, Klas
    Denholt, Charlotte Lund
    Lehel, Szabolcs
    Petersen, Ida Nymann
    Madsen, Jacob
    Erlandsson, Maria
    Ohlsson, Tomas
    Herth, Matthias Manfred
    Gillings, Nic
    PHARMACEUTICALS, 2021, 14 (07)
  • [23] High yield GMP production of [18F]FE-PE2I, a radiotracer for in vivo PET imaging the dopamine transporter
    Moein, Mohammad Mahdi
    Dahl, Kenneth
    Meijer, Ellen
    Ferrat, Melodie
    Tegnebratt, Tetyana
    Saliba, Paul
    Norman, Fredrik
    Samen, Erik
    Steiger, Carsten
    Savitcheva, Irina
    Tran, Thuy
    NUCLEAR MEDICINE AND BIOLOGY, 2022, 108 : S132 - S133
  • [24] Identification of PET radiometabolites by cytochrome P450, UHPLC/Q-ToF-MS and fast radio-LC: applied to the PET radioligands [11C]flumazenil, [18F]FE-PE2I, and [11C]PBR28
    Amini, Nahid
    Nakao, Ryuji
    Schou, Magnus
    Halldin, Christer
    ANALYTICAL AND BIOANALYTICAL CHEMISTRY, 2013, 405 (04) : 1303 - 1310
  • [25] Identification of PET radiometabolites by cytochrome P450, UHPLC/Q-ToF-MS and fast radio-LC: applied to the PET radioligands [11C]flumazenil, [18F]FE-PE2I, and [11C]PBR28
    Nahid Amini
    Ryuji Nakao
    Magnus Schou
    Christer Halldin
    Analytical and Bioanalytical Chemistry, 2013, 405 : 1303 - 1310
  • [26] An efficient one-step radiosynthesis of [18F]FE-PE2I, a PET radioligand for imaging of dopamine transporters
    Stepanov, Vladimir
    Krasikova, Raisa
    Raus, Liina
    Loog, Olavi
    Hiltunen, Jukka
    Halldin, Christer
    JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2012, 55 (06): : 206 - 210
  • [27] Autoradiography and in vivo evaluation in cynomolgus monkey of [18F]FE-PE2I, a new dopamine transporter PET radioligand
    Varrone, Andrea
    Schou, M.
    Steiger, C.
    Takano, A.
    Finnema, S.
    Guilloteau, D.
    Gulyas, B.
    Halldin, C.
    NEUROIMAGE, 2008, 41 : T144 - T144
  • [28] In Vitro Ligand Binding Kinetics Explains the Pharmacokinetics of [18F]FE-PE2I in Dopamine Transporter PET Imaging
    Kukk, Siim
    Loog, Olavi
    Hiltunen, Jukka-Veli
    Jarv, Jaak
    ACS MEDICINAL CHEMISTRY LETTERS, 2018, 9 (12): : 1292 - 1296
  • [29] ANTIPSYCHOTIC DISCONTINUATION IN FIRST EPISODE PSYCHOSIS: [18F] DOPA AND [11C] RACLOPRIDE PET STUDY
    Kim, Euitae
    SCHIZOPHRENIA BULLETIN, 2018, 44 : S382 - S382
  • [30] Longitudinal DAT changes measured with [18F]FE-PE2I PET in patients with Parkinson?s disease; a validation study
    Kerstens, V. S.
    Fazio, P.
    Sundgren, M.
    Brumberg, J.
    Halldin, C.
    Svenningsson, P.
    Varrone, A.
    NEUROIMAGE-CLINICAL, 2023, 37
12345